Est-il justifié de prescrire de l’aspirine après une thrombose veineuse ?
(2014) Louvain médical — Vol. 133, n° 2, p. 59-65 (2014)
Files
2014_Hermans_Lmed_133_59-65.pdf
Restricted Access - Adobe PDF
- 594.97 KB
Details
- Authors
- Abstract
- (en) Antiplatelet agents including aspirin play a well-established role in the prevention and treatment of arterial thrombosis. Low-dose aspirin is frequently prescribed to prevent the recurrence of venous thrombosis. While this attitude is based on little scientific evidence, some recent data has reignited the debate about this specific indication of aspirin in venous thromboembolic patients. The last North American Consensus of the ACCP (American College of Chest Physicans) listed aspirin as a pharmacological option for preventing venous thromboembolic disease following major orthopedic surgery, whereas previous recommendations pleaded against this use. In addition, several recent publications have convincingly demonstrated the efficacy of low-dose aspirin in preventing venous thrombosis recurrence in patients who discontinued oral anticoagulation following an initial venous thrombotic event. In light of this recent data, this article reviews the role of aspirin in the prevention of recurrent venous thrombosis.
- Affiliations
Citations
Hermans, C. (2014). Est-il justifié de prescrire de l’aspirine après une thrombose veineuse ? Louvain médical, 133(2), 59-65. https://hdl.handle.net/2078.5/22252 (Original work published 2014)